We are live on ! Find out more
NAM

NorthCrest Asset Manangement Portfolio holdings

AUM $3.89B
1-Year Est. Return 40.33%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.33%
3 Year Est. Return
+119.87%
5 Year Est. Return
10 Year Est. Return
AUM
$2.4B
AUM Growth
+$642M
Cap. Flow
+$545M
Cap. Flow %
22.67%
Top 10 Hldgs %
17.79%
Holding
509
New
118
Increased
275
Reduced
66
Closed
23

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$30.5M
2
ACN icon
Accenture
ACN
+$16.2M
3
ABBV icon
AbbVie
ABBV
+$14.1M
4
KKR icon
KKR & Co
KKR
+$7.13M
5
SIVB
SVB Financial Group
SIVB
+$6.32M

Sector Composition

Rank Sector Weight
1 Technology 25.34%
2 Industrials 14.45%
3 Healthcare 14.01%
4 Financials 12.09%
5 Consumer Discretionary 5.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDSN icon
326
Nordson
NDSN
$17.2B
$617K 0.03%
2,777
+17
+0.6% +$3.89K
IBB icon
327
iShares Biotechnology ETF
IBB
$9.77B
$611K 0.03%
+4,727
New +$619K
LCID icon
328
Lucid Motors
LCID
$2.58B
$610K 0.03%
+7,593
New +$675K
RJF icon
329
Raymond James Financial
RJF
$34.2B
$607K 0.03%
6,510
CIEN icon
330
Ciena
CIEN
$58.2B
$603K 0.03%
11,476
+176
+2% +$8.79K
NUVA
331
DELISTED
NuVasive, Inc.
NUVA
$602K 0.03%
14,580
+700
+5% +$29.9K
MTG icon
332
MGIC Investment
MTG
$6.22B
$594K 0.02%
44,229
+429
+1% +$5.78K
JEF icon
333
Jefferies Financial Group
JEF
$12.8B
$594K 0.02%
18,700
+1,127
+6% +$40.7K
WAT icon
334
Waters Corp
WAT
$40.4B
$586K 0.02%
1,893
+8
+0.4% +$2.59K
AZTA icon
335
Azenta
AZTA
$1.51B
$581K 0.02%
13,010
+600
+5% +$29.7K
HOPE icon
336
Hope Bancorp
HOPE
$1.78B
$578K 0.02%
58,840
+2,300
+4% +$28.2K
ST icon
337
Sensata Technologies
ST
$6.71B
$578K 0.02%
11,550
+3,258
+39% +$158K
HOLX
338
DELISTED
Hologic
HOLX
$577K 0.02%
7,156
+376
+6% +$30.3K
VUG icon
339
Vanguard Morningstar Growth ETF
VUG
$230B
$569K 0.02%
13,698
+3,450
+34% +$134K
AGYS icon
340
Agilysys
AGYS
$3.09B
$569K 0.02%
6,900
+500
+8% +$40.4K
KEYS icon
341
Keysight
KEYS
$58.5B
$567K 0.02%
3,513
-232
-6% -$39.4K
ENPH icon
342
Enphase Energy
ENPH
$5.45B
$561K 0.02%
2,670
+70
+3% +$15.2K
FTNT icon
343
Fortinet
FTNT
$122B
$556K 0.02%
8,360
+300
+4% +$17.1K
SLF icon
344
Sun Life Financial
SLF
$45.4B
$551K 0.02%
11,802
+2,002
+20% +$96.4K
CSGS
345
DELISTED
CSG Systems International
CSGS
$548K 0.02%
10,200
+700
+7% +$39.8K
VRNT
346
DELISTED
Verint Systems
VRNT
$547K 0.02%
14,700
+1,000
+7% +$37.3K
INCY icon
347
Incyte
INCY
$24.6B
$546K 0.02%
7,558
+78
+1% +$6.1K
NBIX icon
348
Neurocrine Biosciences
NBIX
$16.6B
$546K 0.02%
5,391
+41
+0.8% +$4.27K
VOO icon
349
Vanguard S&P 500 ETF
VOO
$1.03T
$544K 0.02%
1,447
+232
+19% +$85.1K
TXT icon
350
Textron
TXT
$15.3B
$544K 0.02%
7,700

Similar funds

NorthCrest Asset Manangement's Q1 2023 Portfolio in Review

As of Q1 2023, NorthCrest Asset Manangement held 509 positions worth $2.4B, up 36% from $1.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

NorthCrest Asset Manangement deployed $545M of net new capital in Q1 2023, opening 118 new positions and adding to 275 existing holdings. Its largest new stake was Verizon: 830,897 shares worth $32.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $16.2M trimmed.

  • NorthCrest Asset Manangement's largest Q1 2023 buy was Verizon: 830,897 shares worth $32.3M.
  • NorthCrest Asset Manangement added most to Pfizer in Q1 2023, an estimated $21.3M increase.
  • NorthCrest Asset Manangement's biggest Q1 2023 reduction was Accenture, cutting an estimated $16.2M.
  • NorthCrest Asset Manangement fully exited Chevron in Q1 2023, selling an estimated $30.5M.
  • NorthCrest Asset Manangement's ten largest holdings make up 18% of its $2.4B portfolio in Q1 2023.
  • NorthCrest Asset Manangement opened 118 new positions and closed 23 in Q1 2023.
  • NorthCrest Asset Manangement's portfolio value rose 36% quarter-over-quarter to $2.4B.

Based on NorthCrest Asset Manangement's 13F filing for Q1 2023, filed 25 Apr 2023.